Search clinical trials for: Gemtuzumab Ozogamicin
Total 180 results
-
Roswell Park Cancer InstitutePfizerWithdrawnRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Blasts 5 Percent or More of Bone Marrow Nucleated Cells | CD22 Positive | Allogeneic Hematopoietic Stem Cell Transplantation Recipient | Blasts 5 Percent or More of Peripheral Blood White Cells | Lymphoblasts... and other conditionsUnited States
-
Glycotope GmbHCompletedSolid Tumor, AdultGermany, Italy, Spain
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | CD22 PositiveUnited States
-
Grupo Cooperativo de Estudio y Tratamiento de las...CompletedNovo Acute Myeloid LeukemiaSpain
-
Novartis PharmaceuticalsWithdrawn
-
Cardiff UniversityCancer Research UKUnknownMyelodysplastic Syndrome | Acute Myeloid LeukaemiaDenmark, United Kingdom
-
Eli Lilly and CompanyCoLucid PharmaceuticalsCompleted
-
PfizerUCB PharmaCompletedLymphoma, B-CellKorea, Republic of, Canada, Belgium, Singapore, United States, Hong Kong, Japan, United Kingdom, France
-
PfizerCompleted
-
PfizerUCB PharmaCompletedAcute Lymphoblastic LeukemiaUnited States, Canada, France, Spain, China, United Kingdom, Australia, Taiwan, Singapore, Korea, Republic of, Japan, Germany, Czechia, Poland, Italy, Netherlands, Argentina, Finland, Hungary, Sweden
-
PfizerUCB PharmaTerminatedLymphoma, Non-HodgkinCanada, United States, Spain, France, Singapore, Taiwan, Japan, Ireland, Belgium, United Kingdom, Germany, Slovakia, Thailand, Croatia, Czechia, Russian Federation, India, Sweden, Poland, Bulgaria, Hungary, Lithuania, Mexico, Puerto Rico and more
-
PfizerCompletedLymphoma, B-CellUnited States, Spain, France, Switzerland, United Kingdom, Belgium, Germany
-
M.D. Anderson Cancer CenterWyeth is now a wholly owned subsidiary of PfizerTerminated
-
PfizerUCB PharmaCompletedB-Cell LymphomaUnited States, Belgium, Korea, Republic of, Switzerland, France, Poland, Spain, Hong Kong, Australia, Germany, Italy, Netherlands, United Kingdom
-
PfizerUCB PharmaTerminatedLymphoma, FollicularBelgium, United States, Canada, Hong Kong, Korea, Republic of, Portugal, Spain, Poland, India, Argentina, Italy, Mexico, Russian Federation, South Africa
-
PfizerUCB PharmaCompletedLymphoma, B-CellUnited States, France, United Kingdom, Singapore, Korea, Republic of, Germany
-
PfizerUCB PharmaCompletedLymphomaUnited States, Belgium, Japan, Korea, Republic of, Germany, Hong Kong, Hungary, Netherlands, Singapore
-
PfizerUCB PharmaCompletedAcute Lymphocytic LeukemiaUnited States
-
Cristiana SessaCompletedB-cell Lymphoma RefractorySwitzerland
-
The Lymphoma Academic Research OrganisationPfizerCompletedDiffuse Large B-Cell LymphomaFrance, Belgium
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
CSL BehringCompletedHereditary AngioedemaBulgaria, United States, Poland, Spain, Hungary, United Kingdom, Russian Federation, Macedonia, The Former Yugoslav Republic of, Argentina, Australia, Canada, Czech Republic, Israel, Romania, Sweden
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain and Central Nervous System Tumors | NeuroblastomaUnited States
-
University of ZagrebCompletedLuteal Phase DefectCroatia
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)CompletedLeukemia, Myelocytic, AcuteUnited States
-
Grupo Cooperativo de Estudio y Tratamiento de las...Completed
-
PfizerCompletedInvasive CandidiasisCzech Republic, Belgium, Austria, Portugal, Russian Federation, Turkey, Canada, Germany, Italy, United Kingdom, Hungary, France, Slovakia, Denmark, Romania, Netherlands, Poland, Greece, Ukraine
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedLeukemia, Myelocytic, Acute | Infusions, Intravenous
-
PfizerVicuron PharmaceuticalsCompleted